Review: taking Vyvanse and Hydroxyzine together


Summary

Drug interactions are reported among people who take Vyvanse and Hydroxyzine together. This review analyzes the effectiveness and drug interactions between Vyvanse and Hydroxyzine. It is created by eHealthMe based on reports of 47 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Vyvanse and Hydroxyzine >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Vyvanse

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Vyvanse 8,869 users)

Hydroxyzine

Hydroxyzine has active ingredients of hydroxyzine hydrochloride. It is often used in itching. (latest outcomes from Hydroxyzine 9,779 users)

On Aug, 26, 2016

47 people who take Vyvanse, Hydroxyzine are studied.


Number of reports submitted per year:

Vyvanse and Hydroxyzine drug interactions.

Drug effectiveness over time:

Vyvanse:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 60.0% - (3 of 5 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 100.0% - (3 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Hydroxyzine:
  • < 1 month: 25.0% - (2 of 8 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Vyvanse:
  • female: 60.0% - (6 of 10 people)
  • male: 100.0% - (2 of 2 people)
Hydroxyzine:
  • female: 22.0% - (2 of 9 people)
  • male: 0.0% - (0 of 3 people)

Drug effectiveness by age:

Vyvanse:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 33.0% - (1 of 3 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 80.0% - (4 of 5 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Hydroxyzine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 3 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 16.0% - (1 of 6 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • anxiety
  • dry mouth
  • dyspnoea
  • agitated depression
  • agitation
  • breast infection
  • decreased appetite
  • dizziness
  • fatigue
  • heart rate increased
1 - 6 months:
  • fatigue
  • abdominal pain upper
  • agitation
  • breast infection
  • dizziness
  • dry mouth
  • irritability
  • menstruation irregular
  • mood altered
  • muscle spasms
6 - 12 months:
  • mood swings
  • sleep disorder
  • suicidal behaviour
1 - 2 years:
  • mood altered
  • palpitations
2 - 5 years:
  • bedwetting
  • hives
  • urticaria
10+ years:
  • hives
  • urticaria
not specified:
  • dyspnoea
  • death
  • cardiac arrest
  • abnormal behaviour
  • anxiety
  • hypersensitivity
  • insomnia
  • intentional self-injury
  • onychophagia
  • psychomotor hyperactivity

Most common drug interactions by gender *:

female:
  • dyspnoea
  • anxiety
  • death
  • dry mouth
  • fatigue
  • mood swings
  • muscle spasms
  • sleep disorder
  • suicidal behaviour
  • abnormal behaviour
male:
  • pancreatitis
  • abdominal pain upper
  • aggression
  • akathisia
  • blood albumin decreased
  • blood calcium decreased
  • cardiac arrest
  • cardiac disorder
  • cardiomyopathy
  • chest pain

Most common drug interactions by age *:

2-9:
  • mood swings
  • sleep disorder
  • suicidal behaviour
  • mood altered
10-19:
  • anxiety
  • intentional self-injury
  • onychophagia
  • psychomotor hyperactivity
  • trichotillomania
  • abnormal behaviour
  • aggression
  • agitated depression
  • cardiac arrest
  • cardiac disorder
20-29:
  • pancreatitis
  • abdominal pain upper
  • blood albumin decreased
  • blood calcium decreased
  • dyspnoea
  • protein total decreased
30-39:
  • fatigue
  • muscle spasms
  • agitation
  • breast infection
  • cardiac arrest
  • dizziness
  • dry mouth
  • dyspnoea
  • irritability
  • menstruation irregular
40-49:
  • dyspnoea
  • ear discomfort
  • feeling hot
  • genital rash
  • hypertension
  • palpitations
  • pruritus
  • sinusitis
  • therapeutic response unexpected
  • vomiting
50-59:
  • death
  • dyspnoea
  • heart rate increased
  • glossodynia
  • hyperhidrosis
  • sudden death
  • swelling face
  • swollen tongue

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Vyvanse and Hydroxyzine?

Can you answer these questions?

More questions for: Vyvanse, Hydroxyzine

You may be interested in these reviews

More reviews for: Vyvanse, Hydroxyzine

On eHealthMe, Vyvanse (lisdexamfetamine dimesylate) is often used to treat attention deficit hyperactivity disorder. Hydroxyzine (hydroxyzine hydrochloride) is often used to treat itching. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.